| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/22/2002 | CN1350546A 结核诊断测验 TB diagnostic test |
| 05/22/2002 | CN1350544A Chemical systhesis and use of soluble membrane protein receptor domains |
| 05/22/2002 | CN1350519A Reversible aqueous pH Sensitive lipidizing reagents, compositions and methods of use |
| 05/22/2002 | CN1350003A Human hyaloid band B cell epitose fusogenic peptide and its production process |
| 05/22/2002 | CN1085249C production of variant nisin |
| 05/22/2002 | CN1085076C Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 05/21/2002 | USRE37710 Radiometal-binding analogues of luteinizing hormone releasing hormone |
| 05/21/2002 | US6392124 Infectious vectors and clones of plants derived from the turnip mosaic virus (TUMV) |
| 05/21/2002 | US6392123 Regulatory sequences for use in the generation of preferential sex sterility in plants; for generation hybrid seeds |
| 05/21/2002 | US6392122 Apple promoters for expression of transgenes in plants |
| 05/21/2002 | US6392119 Genetically engineered plant for use biological pest control and cancer therapy |
| 05/21/2002 | US6392118 Stable cultures; for controlling cell distribution within artificial organ |
| 05/21/2002 | US6392030 Strawberry promoters and genes |
| 05/21/2002 | US6392029 HIV chemokines |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6392027 Mammalian adrenocorticotropic hormone receptor nucleic acids |
| 05/21/2002 | US6392026 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 05/21/2002 | US6392025 Human NHE3 protein and non-human cells expressing same |
| 05/21/2002 | US6392024 Nucleotide sequences coding freeze resistant polypeptide; for use in food processing and organ transplants |
| 05/21/2002 | US6392023 Nucleotide sequences which codes preferential polypeptide for use in serodiagnostics and vaccine development |
| 05/21/2002 | US6392022 Gene originating in human chondrocyte |
| 05/21/2002 | US6392019 Immunoglobulins for use in human therapeutics and diagnostics for use in treatment of cancer |
| 05/21/2002 | US6392018 Polypeptides for use in the treatment of pathologies associated with inflammatory respone, nervous system disorders and leukemias; for use as a molecular weight control; for use in foods |
| 05/21/2002 | US6392017 Parasitic helminth DiAg2 proteins and uses thereof |
| 05/21/2002 | US6392016 Preferential polypeptide for use in the diagnosis and treatment of tumors; antiproliferative agents |
| 05/21/2002 | US6392015 Organelle targeting protein; for use in treatment of viral disease |
| 05/21/2002 | US6392014 Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications |
| 05/21/2002 | US6392013 Redirection of cellular immunity by protein tyrosine kinase chimeras |
| 05/21/2002 | US6391858 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
| 05/21/2002 | US6391857 Methods and compositions for endothelial binding |
| 05/21/2002 | US6391855 Compounds and methods for modulating junctional adhesion molecule-mediated functions |
| 05/21/2002 | US6391854 Water soluble hypoglycemic agents |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391852 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/21/2002 | US6391850 Methods and compositions for inhibiting angiogenesis |
| 05/21/2002 | US6391848 Soybean protein nutraceuticals |
| 05/21/2002 | US6391847 Modulating transcription |
| 05/21/2002 | US6391655 Oxidized styrenic polymers for DNA binding |
| 05/21/2002 | US6391651 Materials and methods for detection of insulin dependent diabetes |
| 05/21/2002 | US6391640 Methods and compositions for cellular and metabolic engineering |
| 05/21/2002 | US6391639 Regulatory sequence for use generating transgenic plants; for use in expression of heterologus genes in plants |
| 05/21/2002 | US6391637 Activating genetically engineered cells to generate preferential immunoglobulins; obtain cells, incubate with preferential polypeptides, recover preferential immunoglobulins |
| 05/21/2002 | US6391634 Monoclonal antibodies and their production and use |
| 05/21/2002 | US6391633 Genetically engineered cells for use as tools in the expression of heterologous genes |
| 05/21/2002 | US6391632 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 05/21/2002 | US6391614 Auxiliary gene and protein of methicillin resistant bacteria and antagonists thereof |
| 05/21/2002 | US6391613 Motor proteins and methods for their use |
| 05/21/2002 | US6391612 Replicating preferential plasmids; obtain nuclelotide sequences, transform cells, allow replication, recover plasmids |
| 05/21/2002 | US6391609 Generation solution containing blood proteins; extract mammalian tissue, separate coagulaton factors, recover purfied blood protein |
| 05/21/2002 | US6391606 Peptides; for use in the develoment of human diagnostic and therapeutic agents |
| 05/21/2002 | US6391603 Genes of purine biosynthesis from Ashbya gossypii and the use thereof in microbial riboflavin synthesis |
| 05/21/2002 | US6391601 Transport protein for use in the treatment of cell proliferation defects, cancer, hyperplasias, restenosis, cardiovascular, immune and inflammatory disorders |
| 05/21/2002 | US6391590 Generation hybrid polypeptide; obtain cell, transform cells with expression vector, recover hybrid polypeptide |
| 05/21/2002 | US6391589 Human chemokine beta-10 mutant polypeptides |
| 05/21/2002 | US6391588 Nucleotides squences coding preferential amino acid sequences for use in treating bone disorder in mammals |
| 05/21/2002 | US6391587 Nucleotide sequences for use in the prevention of microorganismal infections |
| 05/21/2002 | US6391585 Plasmid for use as tool in generation of genetic engineering heterologous proteins |
| 05/21/2002 | US6391584 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 05/21/2002 | US6391581 DNA encoding interleukin-4 receptors |
| 05/21/2002 | US6391580 Ras proteins |
| 05/21/2002 | US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects |
| 05/21/2002 | US6391572 Incubating fragments of transcription factors c-jun protein and stat3 protein with and without agent, detecting binding of those proteins in each mixture; alteration of binding indicates modulator |
| 05/21/2002 | US6391571 Mutein which is capable of binding to biotin but has a low affinity for it; for use as interference elimination reagent in analyses |
| 05/21/2002 | US6391569 Method to detect Dirofilaria immitis infection |
| 05/21/2002 | US6391567 Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
| 05/21/2002 | US6391566 Drug screening of ligands which interact with receptor of defined amino acid sequence incubating by incubating ligand with recombinant cell or membrane which expresses receptor |
| 05/21/2002 | US6391565 Methods of detecting growth differentiation factor-3 |
| 05/21/2002 | US6391561 Introducing crna molecule encoding k+ channel associated protein and and crna encoding kv alpha subunit into host cell and then co-expressing those proteins |
| 05/21/2002 | US6391543 Screening sample for preferential nucleotide sequences; incubate sample with nucleotide sequences, monitor sample for signal indicating bound nucleotide sequences |
| 05/21/2002 | US6391542 Oligonucleotides of defined nucleotide sequence; antisense agents; viricides; diagnostic probes |
| 05/21/2002 | US6391539 Immunogenic compositions of human papillomavirus |
| 05/21/2002 | US6391452 Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations |
| 05/21/2002 | US6391362 Pasteurizing unhomogenized milk, whipping into a cream phase and a first aqueous phase, separating the cream phase and washing with water over 15-36 hours, drying; dairy or diagnostic purposes |
| 05/21/2002 | US6391316 Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use |
| 05/21/2002 | US6391314 Immunogenic composition comprising vector that contains and expresses in vivo in porcine host cell, nucleic acid molecule or fragment thereof encoding type ii porcine circovirus antigen and pharmaceutically acceptable vehicle or diluent |
| 05/21/2002 | US6391311 Polypeptide comprising amino acid sequence at least about 80% identical to specified sequence, which has biological activity of promoting selective growth and/or survival of human umbilical vein endothelial cells in in vitro assay |
| 05/21/2002 | US6391304 Medicinal product capable of inducing protection in feline host against infection with feline immunodeficiency virus, comprising isolated peptide consisting of or containing specified amino acid sequence |
| 05/21/2002 | US6391296 Method of stabilizing useful protein and useful protein compositions |
| 05/21/2002 | US6391285 Antimicrobial polypeptide and methods of use |
| 05/21/2002 | CA2215745C Human stat4 |
| 05/21/2002 | CA2183241C Yeast strains and modified albumins |
| 05/21/2002 | CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same |
| 05/21/2002 | CA1341361C Human erythropoietin gene: high level expression in stably transfected mammalian cells |
| 05/20/2002 | WO2002039947A2 Carrier vectors through an epithelium with tight junctions |
| 05/16/2002 | WO2002039431A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/16/2002 | WO2002039116A2 Retrovirus isolated from humans |
| 05/16/2002 | WO2002038805A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 05/16/2002 | WO2002038803A2 Novel marker for the diagnosis and therapy of tumours |
| 05/16/2002 | WO2002038796A2 Methods for determining protease cleavage site motifs |
| 05/16/2002 | WO2002038795A2 Braf35 protein and brca2/braf35 complex and methods of use |
| 05/16/2002 | WO2002038793A2 Hepatitis c virus constructs characterized by high efficiency replication |
| 05/16/2002 | WO2002038770A1 Yeast derived vaccine against ipnv |
| 05/16/2002 | WO2002038769A2 Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2 |
| 05/16/2002 | WO2002038768A1 Manipulation of plant life cycles and/or growth phases |
| 05/16/2002 | WO2002038767A2 G protein-coupled receptor protein and nucleic acid molecules and uses therefor |
| 05/16/2002 | WO2002038766A2 Human tumor necrosis factor receptor |
| 05/16/2002 | WO2002038765A2 Dna encoding bovine immunoglobulin a inducing protein and uses therefor |
| 05/16/2002 | WO2002038764A2 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage |
| 05/16/2002 | WO2002038763A1 Pca2501 gene |
| 05/16/2002 | WO2002038761A2 Regulation of human oat-like protein |